• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 associated with concomitant mucormycosis and aspergillosis.

作者信息

Lai Chih-Cheng, Wu Chi-Jung, Lee Yi-Chien, Liu Wei-Lun

机构信息

Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan City, Taiwan.

National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan City, Taiwan; Division of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.

出版信息

J Microbiol Immunol Infect. 2022 Apr;55(2):353-354. doi: 10.1016/j.jmii.2021.09.001. Epub 2021 Sep 20.

DOI:10.1016/j.jmii.2021.09.001
PMID:34563471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8450135/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e79/8450135/e79245a67c3e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e79/8450135/e79245a67c3e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e79/8450135/e79245a67c3e/gr1_lrg.jpg

相似文献

1
COVID-19 associated with concomitant mucormycosis and aspergillosis.与毛霉菌病和曲霉菌病并发的新型冠状病毒肺炎
J Microbiol Immunol Infect. 2022 Apr;55(2):353-354. doi: 10.1016/j.jmii.2021.09.001. Epub 2021 Sep 20.
2
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.新型冠状病毒肺炎相关混合霉菌感染：1例曲霉病和毛霉病病例报告及文献综述
J Mycol Med. 2022 Mar;32(1):101231. doi: 10.1016/j.mycmed.2021.101231. Epub 2021 Nov 26.
3
Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.糖尿病患者合并曲霉病和毛霉菌病双重真菌感染致上颌窦炎：COVID-19 后首例报告。
Acta Medica (Hradec Kralove). 2021;64(4):227-231. doi: 10.14712/18059694.2022.7.
4
Invasive mucormycosis and aspergillosis in a healthy 22-year-old battle casualty: case report.健康 22 岁战斗伤员的侵袭性毛霉病和曲霉菌病：病例报告。
Surg Infect (Larchmt). 2011 Oct;12(5):397-400. doi: 10.1089/sur.2010.065. Epub 2011 Oct 17.
5
Mucormycosis: A killer in the shadow of COVID-19.毛霉菌病：新冠疫情阴影下的杀手
J Mycol Med. 2021 Sep;31(3):101161. doi: 10.1016/j.mycmed.2021.101161. Epub 2021 May 31.
6
Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.口面部曲霉菌病和毛霉菌病合并症：复发性小儿胶质瘤的致命并发症——病例报告及文献综述
Mycopathologia. 2016 Oct;181(9-10):723-33. doi: 10.1007/s11046-016-0021-8. Epub 2016 Jun 27.
7
Mixed mold infection with and in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）患者合并 和 的混合霉菌感染。 （你提供的原文中“ 和 ”部分内容缺失，请补充完整以便更准确翻译）
Infect Dis Now. 2021 Oct;51(7):633-635. doi: 10.1016/j.idnow.2021.01.010. Epub 2021 Jan 27.
8
Coronavirus disease 2019 associated pulmonary mucormycosis.2019冠状病毒病相关肺毛霉病
Infection. 2023 Oct;51(5):1601-1602. doi: 10.1007/s15010-023-02038-3. Epub 2023 Apr 17.
9
Post-COVID-19 Intestinal and Mesenteric Mucormycosis.新冠后肠和肠系膜毛霉菌病。
Am Surg. 2023 Jun;89(6):2770-2773. doi: 10.1177/00031348211048841. Epub 2021 Nov 3.
10
Multiple Gastric Ulcers in An Immunosuppressed Patient with COVID-19 Infection caused by Mucormycosis.一名感染新冠病毒的免疫抑制患者因毛霉菌病引发多处胃溃疡
J Gastrointestin Liver Dis. 2024 Mar 29;33(1):16. doi: 10.15403/jgld-5149.

引用本文的文献

1
Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review.经支气管内两性霉素 B 灌注成功治疗混合性肺曲霉和毛霉感染：病例报告及文献复习。
BMC Pulm Med. 2024 Sep 4;24(1):436. doi: 10.1186/s12890-024-03234-z.
2
Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review.多次静脉输注脐带间充质干细胞治疗成人重症新型冠状病毒肺炎相关急性呼吸窘迫综合征的文献综述
Stem Cells Int. 2023 Aug 18;2023:7179592. doi: 10.1155/2023/7179592. eCollection 2023.
3

本文引用的文献

1
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.ECMM/ISHAM 关于中低收入国家 COVID-19 相关毛霉菌病临床管理的建议。
Mycoses. 2021 Sep;64(9):1028-1037. doi: 10.1111/myc.13335. Epub 2021 Jul 26.
2
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.SARS-CoV-2 与其他病原体合并感染和继发感染的流行率和结局：系统评价和荟萃分析。
PLoS One. 2021 May 6;16(5):e0251170. doi: 10.1371/journal.pone.0251170. eCollection 2021.
3
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19.
Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment.
新型冠状病毒病 2019 经奈玛特韦/利托那韦治疗后复发。
J Med Virol. 2023 Feb;95(2):e28430. doi: 10.1002/jmv.28430.
4
COVID-19 Associated with Cryptococcosis: A New Challenge during the Pandemic.新型冠状病毒肺炎合并隐球菌病：大流行期间的新挑战
J Fungi (Basel). 2022 Oct 21;8(10):1111. doi: 10.3390/jof8101111.
5
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.新型冠状病毒肺炎相关混合霉菌感染：1例曲霉病和毛霉病病例报告及文献综述
J Mycol Med. 2022 Mar;32(1):101231. doi: 10.1016/j.mycmed.2021.101231. Epub 2021 Nov 26.
一名新冠肺炎患者的肺曲霉病和毛霉病
Med Mycol Case Rep. 2021 Jun;32:64-67. doi: 10.1016/j.mmcr.2021.03.006. Epub 2021 Apr 7.
4
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病：2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
5
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?COVID-19 患者的合并感染：是否需要使用非抗 SARS-CoV-2 药物进行联合治疗？
J Microbiol Immunol Infect. 2020 Aug;53(4):505-512. doi: 10.1016/j.jmii.2020.05.013. Epub 2020 May 23.